Investigating the prognostic value of KOC (K homology domain containing protein overexpressed in cancer) overexpression after curative intent resection of pancreatic ductal adenocarcinoma.

Johnson, Benny; Khalil, Maged; Blansfield, Joseph; Lin, Fan; Zhu, Shaobo; Kirchner, H Lester; Weir, Alva B

Johnson, Benny; Khalil, Maged; Blansfield, Joseph; Lin, Fan; Zhu, Shaobo; Kirchner, H Lester; Weir, Alva B.

Afiliación

Johnson B; Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA.
Khalil M; Lehigh Valley Hospital, The Lehigh Valley Health Network, Allentown, PA, USA.
Blansfield J; Geisinger Medical Center, Geisinger Health System, Danville, PA, USA.
Lin F; Geisinger Medical Center, Geisinger Health System, Danville, PA, USA.
Zhu S; Geisinger Medical Center, Geisinger Health System, Danville, PA, USA.
Kirchner HL; Geisinger Medical Center, Geisinger Health System, Danville, PA, USA.
Weir AB; The University of Tennessee Health Science Center & The West Cancer Center, Memphis, TN, USA.

J Gastrointest Oncol ; 7(6): E113-E117, 2016 Dec.

Article en En | MEDLINE | ID: mdl-28078135

Palabras clave

KOC/IGF2BP3; Pancreatic ductal adenocarcinoma (PDAC); biomarker; neoadjuvant therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Gastrointest Oncol Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google